him glp 1 Hims & Hers promotes GLP-1 obesity drugs in New York Times him glp 1 booster Amazon.com:

In patients with chronic kidney disease but not cardiovascular disease, the NNT is 77 (95% CI, 56 to 167) over five years

After an oral glucose load or a meal, this DPP-4 inhibition resulted in a 2- to 3-fold increase in circulating levels of active GLP-1 and GIP, decreased glucagon concentrations, and increased responsiveness of insulin release to glucose, resulting in higher C-peptide and insulin concentrations

Creatine supplementation can also improve overall cognitive function and memory

doi: 10.1186/1550-2783-2-2-38 51

It supports scalp condition, renewal signalling and the environment surrounding the hair follicle